P
ProKidney Corp
NASDAQ:PROK
ProKidney Corp
NASDAQ:PROK
Price:
1.91
USD
-2.05%
Market Closed
Market Cap:
$574.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
ProKidney Corp
NASDAQ:PROK
|
US |
|
Ansal Buildwell Ltd
BSE:523007
|
IN |
|
Prataap Snacks Ltd
NSE:DIAMONDYD
|
IN |
|
NuGene International Inc
OTC:NUGN
|
US |
|
V
|
Vunani Ltd
JSE:VUN
|
ZA |
|
Golden Wheel Tiandi Holdings Company Ltd
HKEX:1232
|
CN |
|
Tesec Corp
TSE:6337
|
JP |
|
Cados Corp
TSE:211A
|
JP |
Multiples-Based Value
The Multiples-Based Value of one PROK stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.91 USD, ProKidney Corp is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PROK Multiples-Based Value
LOCKED
Multiples Across Competitors
PROK Competitors Multiples
ProKidney Corp Competitors
ProKidney Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
P
|
ProKidney Corp
NASDAQ:PROK
|
575m USD | 643.9 | -8.3 | -1.9 | -1.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.4 | 39.8 | 43.2 | 44.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
